Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Melanoma × Fulvestrant × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Neoplasm Metastasis 2 Neoplasms 1 Melanoma 1 HER2-positive Breast Cancer 1 Brest Cancer 1 Breast Diseases 1 Breast Cancer Metastatic 1 Advanced/Metastatic Solid Tumors 1 Advanced Unresectable or Metastatic Breast Cancer of Adults 1 Advanced Breast Cancer 1

Interventions

Nivolumab 2 Melphalan 2 Interleukin-2 2 trametinib 1 toripalimab 1 sulforaphane 1 secukinumab 1 relatlimab 1 pembrolizumab 1 encorafenib 1 binimetinib 1 anlotinib 1 Toll-Like Receptor 1 1 Therapeutics 1 Standard of Care 1 Specimen Handling 1 Rehabilitation 1 Ipilimumab 1 Injections 1 Immune Checkpoint Inhibitors 1 Fulvestrant 1 Doxorubicin 1 Atorvastatin 1 Afatinib 1 3-(3'-adamantan-1-yl-4'-methoxybiphenyl-4-yl)-2-propenoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07340619 2026-01-14

EPIBREAST

UNICANCER

Phase 2 Not yet recruiting

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡